Owlet, Inc. (OWLT)
16.19
+0.16
(+1.00%)
USD |
NYSE |
Dec 31, 16:00
16.21
+0.02
(+0.12%)
Pre-Market: 20:00
Owlet Research and Development Expense (Quarterly): 3.785M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Apyx Medical Corp. | 0.801M |
| Nephros, Inc. | 0.338M |
| Perspective Therapeutics, Inc. | 19.56M |
| Xtant Medical Holdings, Inc. | 0.634M |
| VolitionRX Ltd. | 2.022M |